Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death.

MLA

Law, Mary E., et al. “Inhibitors of ERp44, PDIA1, and AGR2 Induce Disulfide-Mediated Oligomerization of Death Receptors 4 and 5 and Cancer Cell Death.” Cancer Letters, vol. 534, May 2022, p. 215604. EBSCOhost, https://doi.org/10.1016/j.canlet.2022.215604.

APA

Law, M. E., Yaaghubi, E., Ghilardi, A. F., Davis, B. J., Ferreira, R. B., Koh, J., Chen, S., DePeter, S. F., Schilson, C. M., Chiang, C.-W., Heldermon, C. D., Nørgaard, P., Castellano, R. K., & Law, B. K. (2022). Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death. Cancer Letters, 534, 215604. https://doi.org/10.1016/j.canlet.2022.215604

Chicago

Law, Mary E, Elham Yaaghubi, Amanda F Ghilardi, Bradley J Davis, Renan B Ferreira, Jin Koh, Sixue Chen, et al. 2022. “Inhibitors of ERp44, PDIA1, and AGR2 Induce Disulfide-Mediated Oligomerization of Death Receptors 4 and 5 and Cancer Cell Death.” Cancer Letters 534 (May): 215604. doi:10.1016/j.canlet.2022.215604.